Signal transduction promoted by neurotransmitters, circulating hormones and growth factors is critically important in the regulation of the kidney and vasculature. Many such regulators produce their effects by an interaction with plasma membrane receptors and subsequent perturbation of pathways that modulate metabolic activity, growth, death and differentiated functions of the target cells. The application of various experimental approaches and the elucidation of the crystal structure of G-proteincoupled receptors (GPCRs) and certain receptor tyrosine kinases (RTKs) have provided new insights regarding their activation and regulation [1,2 ,3,4 ,5-12].
Introduction
Signal transduction promoted by neurotransmitters, circulating hormones and growth factors is critically important in the regulation of the kidney and vasculature. Many such regulators produce their effects by an interaction with plasma membrane receptors and subsequent perturbation of pathways that modulate metabolic activity, growth, death and differentiated functions of the target cells. The application of various experimental approaches and the elucidation of the crystal structure of G-proteincoupled receptors (GPCRs) and certain receptor tyrosine kinases (RTKs) have provided new insights regarding their activation and regulation [1,2 ,3,4 ,5-12].
Studies of receptor structure have occurred in parallel with those that have defined the expression and organization in the plasma membrane of receptors and postreceptor components. The concept that membrane lipids and proteins are found in microdomains is supported by a vast literature [13 ,14 ,15 ,16,17 ] . Data obtained from the application of various biophysical and biochemical approaches have furthered the concept that certain lipids, for example cholesterol and sphingolipids, selectively localize in membrane (lipid) raft domains that have decreased fluidity (increased 'liquid order') and greater buoyancy (following fractionation by density gradient centrifugation) than other portions of the plasma membrane [18, 19] . Inclusion of the protein caveolin (there are three isoforms: caveolin-1, caveolin-2 and caveolin-3) in raft domains promotes the formation and detection (by electron microscopy) of caveolae ('little caves'), membrane invaginations 50-100 nm in diameter. Cavin, a protein also known as polymerase I and transcript release factor, has been recently shown to be important for the formation and maintenance of caveolae [20 ,21 ] .
Membrane rafts and caveolae concentrate a subset of membrane constituents, including proteins ( Fig. 1 ) and other components involved in transport and signal transduction [13 ,15 ,16,17 ,22,23 ] . The ability to detect morphologic caveolae and the use of anticaveolin antibodies for immunoprecipitation and colocalization of caveolin-interacting proteins has helped identify partners that bind to caveolins and localize in caveolae. Proteomic and lipidomic methods should aid in the assessment of raft/caveolae constituents and their changes in physiologic states and disease settings [24] [25] [26] [27] .
Rafts/caveolae have a nonhomogeneous organization of signaling entities that facilitates temporally and spatially efficient cellular regulation by extracellular hormones and growth factors. The interiors of cells have gradients of second messengers and effectors [e.g. cyclic AMP (cAMP), Ca 2þ , protein kinases/phosphatases], implying that local enrichment of messengers and effectors create 'signaling factories' surrounded by moats that delimit signals [23 ,28-32,33 ,34,35] . Other such components include phosphodiesterases that hydrolyze cyclic nucleotides, thereby curtailing the activation of effectors (e.g. protein kinase A, exchange protein activated by cAMP, cyclic nucleotide-gated channels in the case of cAMP), protein phosphatases that limit the extent and duration of protein phosphorylation, and A-kinase-anchoring proteins (AKAPs), which bind and organize proteins involved in cAMP-regulated signal transduction, including by vasopressin in the kidney [36] [37] [38] .
In addition to proteins that regulate cAMP generation and action, lipids and proteins involved in other types of signal transduction localize to rafts and caveolae, especially in cardiovascular cells [31, 39] . The precise determinants for such localization are not fully understood, but one contributor is the caveolin-scaffolding domain (CSD), an approximately 20 amino acid region on caveolins, to which partners bind [16,17 ,39] . Peptides that mimic the CSD, including cavtratin, a synthetic cellpermeable caveolin-1 CSD peptide, can block caveolin-mediated signaling and responses and may have therapeutic potential for the treatment of inflammation, tissue fibrosis, pulmonary hypertension and unstable atherosclerotic plaques [40-42,43 ,44] . Membrane rafts that lack caveolins also concentrate signaling molecules, implying that other factors (e.g. binding to lipids) contribute to the interaction of signaling entities with rafts and caveolins. Use of multiple techniques to assess rafts/ caveolae and their partners is preferred, as no one approach is ideal and complementary results from the use of multiple techniques strengthen conclusions regarding localization of components and the contribution of rafts/caveolae in physiologic and pathophysiologic settings. Recent publications review methods to study rafts and caveolae [16,17 ,45] .
Publications on rafts and caveolae are occurring at a very rapid rate (>500 in the last year). In the present review, we provide a sampling of such data with a focus on expression, function and contribution to the pathophysiology of vascular endothelial and smooth muscle, cardiac and renal rafts/caveolae.
Vascular endothelial and renal epithelial caveolae
Substantial data, including electron microscopic, immunochemical and biochemical analyses, indicate that vascular endothelial cells are highly enriched in caveolae. Pulmonary vascular endothelial cells have been used for many types of studies, including proteomic identification of caveolin-associated proteins [25, 46] . Proteomic methods reveal that vascular endothelial cell caveolae contain more than 100 proteins [25] and suggest that caveolae interact with intracellular organelles, including the endoplasmic reticulum and mitochondria [47] . Further use of proteomic and lipidomic approaches should aid in identifying endothelial raft/caveolae-associated constituents [48] .
A large number of signaling molecules that regulate vascular endothelial cells localize in rafts/caveolae. These include receptors (e.g. RTKs, GPCRs and certain steroid receptors), low-molecular-weight and heterotrimeric Gproteins and 'downstream' enzymes and components that serve as effectors of extracellular signals and in transport (e.g. endocytotic) machinery. Such downstream components can be regulated by RTKs, GPCRs and Gproteins [16,49 ,50-52] . Caveolin-1 has been shown to interact with activin receptor-like kinase 1 (ALK1), a transforming growth factor-b (TGF-b) type I membrane receptor expressed primarily on endothelial cells and involved in vascular remodeling and angiogenesis; the TGF-b type I receptor, ALK5 and the TGF-b type II receptor also localize in caveolae [53] . Increased cholesterol can inhibit TGF-b responsiveness by increasing the accumulation of TGF-b receptors in rafts/caveolae, thereby facilitating the degradation of TGF-b and suppressing TGF-b-induced signaling; conversely, treatments that deplete cholesterol [e.g. statins and methyl-b-cyclodextrin (MbCD)] can enhance the response to TGF-b by increasing nonraft accumulation of TGF-b receptors and facilitating TGF-b-induced signaling. Such results suggest that alteration in TGF-b
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Figure 1 Caveolae and caveolae-resident proteins known to interact with the caveolin-scaffolding domain, other classes of signaling molecules that are found in caveolae and some of the functional roles attributed to raft/caveolae-localized components in vascular endothelial, smooth muscle cells and cardiac myocytes CSD, caveolin-scaffolding domain; EGF-R, epidermal growth factor receptor; eNOS, endothelial nitric oxide synthase; GPCRs, G-proteincoupled receptors; PDGF-R, platelet-derived growth factor receptor; PKA, protein kinase A; PKC, protein kinase C; RTKs, receptor tyrosine kinases; TRPC, transient receptor potential channels; VDCC, voltagedependent Ca 2þ channels; VEGF-R, vascular endothelial growth factor receptor.
responsiveness contributes to the promotion of atherogenesis by increased cholesterol levels [54] . Caveolae and caveolin-1 also participate in endothelium-derived hyperpolarizing factor-mediated relaxation by regulating the location and activity of transient receptor potential vanilloid-related type-4 channels and connexins [55 ] . Other signaling events, including redox signaling and response to shear stress, occur in endothelial caveolae and may contribute to cardiovascular health and disease [56] [57] [58] .
Endothelial nitric oxide synthase (eNOS, NOS3) is the most extensively studied caveolae-localized signaling molecule that is important for vascular function [58,59,60 ,61-63] . Recent studies on endothelial cells emphasize the internalization of caveolae in regulating the activation of eNOS [64] , a role for protein nitration by eNOS and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase colocalized in rafts/caveolae [65] , the regulation of localization and cellular trafficking of eNOS by S-nitrosylation [66] and the ability of heat shock protein 90 to dissociate eNOS from caveolae and protect eNOS from proteolysis by calpain, a calcium-activated protease [67] . Caveolins and caveolae have been implicated in dietary sodium-induced changes in vascular tone regulated by eNOS [68] , in the inhibition of eNOS by AMP-activated protein kinase that acts through Rac1 and Akt [69] and in the regulation of matrix metalloproteinase-13 (MMP-13) protein-tyrosine nitration by nitric oxide that leads to its release from endothelial cells, angiogenesis and wound repair [70] .
Transcytosis is an important property of the vascular endothelium, whereby molecules are exchanged bidirectionally between the vascular lumen and cells and across cells into the subendothelial environment. Such bidirectional movement occurs across endothelial caveolae by one or more mechanisms that include fluid phase, adsorptive and receptor-mediated endocytosis. Transcytosis through caveolae regulates endothelial barrier function, participates in angiogenesis and contributes, along with changes in signal transduction, to vascular disease [58,71 ,72-76] .
Caveolae and rafts regulate renal function by effects in vascular endothelial cells and tubular epithelial cells along the nephron. Lipid rafts play important roles in intestinal and renal epithelial brush border membranes [77] . Recent proteomic data define proteins enriched in detergent-resistant membranes (rafts), in rat renal inner medullary collecting duct cells, particularly in response to vasopressin [78] . Renal epithelial cells provide model systems to explore the expression and functional roles of caveolins in membrane structure and transport [79] [80] [81] [82] and cellular invasion by pathogens [83, 84] . Expression of caveolin-1 occurs at various locations in the kidney, for example trafficking of epithelial sodium channel in mouse cortical collecting duct cells [85] . In humans, caveolin-1 localizes in parietal epithelial cells within Bowman's capsule; decreased caveolin-1 expression occurs in the kidneys of patients with focal segmental glomerulosclerosis, lupus glomerulonephritis and unilateral ureteropelvic junction obstruction [86 ,87] . Increased expression of a caveolin-associated protein, PV-1, has been observed in the glomerular capillaries of patients with renal transplant glomerulopathy, the extent of such expression correlating with the grade of glomerulopathy and proteinuria [88] . Epithelial differentiation may, at least in part and perhaps indirectly, depend on caveolin-1 expression in adjacent stromal cells [89] . Caveolin-1/caveolae have been implicated in regulating TGF-b-induced RhoA activation that leads to collagen and fibronectin accumulation in mesangial cells and perhaps in fibrotic renal disease [90] . Other data indicate that renal proximal tubule epithelial cells in spontaneous hypertensive rats (SHRs) and Wistar-Kyoto (WKY) controls differ in their sensitivity to angiotensin II; higher H 2 O 2 generation in SHRs leads to enhanced expression of glycosylated and nonglycosylated angiotensin II type 1 receptors by rafts [91 ] . The interaction of cAMP formation and annexin-2 in rafts may regulate the trafficking of aquaporin-2 to the apical plasma membrane [92] , although others question whether another aquaporin, aquaporin-1, localizes in lipid rafts [93] .
Vascular smooth muscle caveolae
The lungs, in particular the pulmonary vasculature, have the highest expression of caveolae in the body [94] . Vascular caveolae are functionally important in both the endothelium and smooth muscle, providing a location for the interaction of receptors, ion channels, signal transduction, kinases and other effector molecules, thereby helping to regulate cellular signaling pathways [17 ] . Ca 2þ flux and intracellular Ca 2þ levels are important regulators of smooth muscle physiology; numerous components in the Ca 2þ -handling machinery [plasma membrane Ca 2þ pump, Na þ -Ca 2þ exchanger, voltagedependent Ca 2þ channels and transient receptor potential channels (TRPCs)] localize to and are regulated in caveolae [95, 96] . The suggestion that caveolae form 'nanocontacts' with the sarcoplasmic reticulum [97 ] provides an additional level of organization and control of Ca 2þ signaling in smooth muscle. This concept may help explain how Ca 2þ -induced Ca 2þ release and triggering of store-operated Ca 2þ channels (a subset of TRPC) occur. Recent data implicate caveolae in the regulation of Ca 2þ sensitization in smooth muscle contraction and in downstream kinase signaling associated with shear stress. In addition, disruption of caveolar structure perturbs responses to physiological agonists as a function of the proteins in caveolae [98] . For example, caveolae may be conduits for the regulation of intracellular Ca 2þ and may enrich Ca 2þ -sensitive signaling [99] . The CSD of caveolin may be sufficient to produce physiological effects. Treatment of human arterial smooth muscle cells with the CSD of caveolin-1 or caveolin-3 can inhibit angiotensin II-promoted increase in intracellular Ca 2þ [42] . This result raises the intriguing possibility that caveolin, in particular the CSD, might be a target in the treatment of vascular disease.
A setting of smooth muscle pathophysiology that is affected by aberrant Ca 2þ signaling is pulmonary arterial hypertension (PAH), which can be idiopathic (IPAH, with unknown cause) or secondary to other disorders [100] . The level of caveolin expression may contribute to the PAH phenotype although there is controversy as to whether the expression is increased or decreased. Caveolin-1 knockout mice have PAH, which appears attributable to remodeling of pulmonary precapillary vessels [101] . Caveolin-1 expression is reduced in the lungs of patients with IPAH and in animal models of PAH such as hypoxic-treated and monocrotaline-treated rats [102, 103 ] . A reduction in caveolin-1 expression is observed in the plexiform lesions [consisting of proliferating pulmonary arterial endothelial cells (PAEC)] that accompany IPAH and, because of the high expression of caveolae in PAEC, likely accounts for the overall reduction in caveolin expression in the lungs of patients with IPAH [102] . In contrast, caveolin-1 and caveolae expression are increased in pulmonary arterial smooth muscle cells (PASMCs) of patients with IPAH in association with increased function, including hyperproliferation and enhanced Ca 2þ -induced Ca 2þ entry [103 ] . The decrease in caveolin-1 expression in IPAH-PAEC compared with the increase in IPAH-PASMC indicates that cell-specific changes in caveolin-1 expression and function occur in this disease, and perhaps in others.
Cardiac caveolae
Two important aspects of high-fidelity signaling are the ability to regulate the 'turn on' and 'turn off' of the signal. A third key additional feature in signal transduction is the need to limit basal or 'leaky' signaling. In this regard, cardiac caveolae may help limit unsolicited activity of signaling molecules; caveolin-3 knockout mice have an approximately 40% increase in myocardial cAMP content [104] , and cardiac myocytes treated with MbCD have a 60-70% increase in phosphorylation of protein kinase A targets, suggesting that disruption of caveolae results in the dysregulation of cAMP generation [105] . This dysregulation may be secondary to enhanced Gs-promoted signaling or loss of Gi-mediated inhibition of adenylyl cyclase activity [106] . Other studies show that basal signaling activity of b 2 -adrenergic receptors is enhanced by cholesterol depletion and can be suppressed by increased expression of caveolin or increasing membrane cholesterol [107 ] . Understanding how caveolae regulate basal signaling and how this is perturbed by disease could provide novel insights into cardiovascular physiology and pharmacology.
Caveolae in cardiac myocytes are major sites of GPCR expression and ionic flux [16, 39, 108 ] . The ability of caveolae to enrich and regulate various channels may help coordinate signaling events, whereas defects in these associations may contribute to cardiac arrhythmias [109] . Caveolin-1 can traffic Kv1.5 channels to lipid-rich (raft) regions that modulate channel function [110] ; caveolin-trafficking mutants trap Kv1.5 channel expression within the cell, thereby limiting plasma membrane expression of the channel. In addition, lipid-rich microenvironments in myocytes distinct from caveolae are key to Kv1.5 channel localization and function; depletion of membrane cholesterol changes channel current in the absence of colocalization with caveolin-3 [111] . Other data confirm that Kv1.5 is not present in cardiac myocyte caveolae [112] . These studies suggest that myocyte caveolins have a trafficking function distinct from a structural role. As caveolin-3 is the isoform in myocytes that is necessary for caveolae formation, perhaps caveolin-1 has a different role, that is, transporting components to lipid-rich compartments.
The role of caveolae in regulating cardiac injury after ischemia and ischemia/reperfusion has recently received much attention. Studies conducted with adult cardiac myocytes in vitro reveal that disruption of caveolae with cholesterol-depleting agents (e.g. MbCD) eliminates protection (induced by a preconditioning, short ischemic stimulus, or opioids) from damage by hypoxia reperfusion [113] . Studies of intact hearts confirm these data [114] . Cholesterol-depleting compounds such as MbCD do not differentiate between rafts and caveolae, and, thus, it is important to confirm conclusions obtained by their use in other ways such as with caveolin knockout mice. Both caveolin-1 and caveolin-3 knockout mice are resistant to cardiac protection from ischemia/reperfusion injury [115, 116] , although only caveolin-3 knockout mice lack morphological caveolae in cardiac myocytes. Thus, caveolins may have roles other than through caveolae in cardiac protection. Caveolin-1 and caveolin-3 exist in atria [117] , but data for ventricles are equivocal. Caveolin-1 knockout mice have loss of protection in the ventricles and appear to have altered cardiac MMP activity with colocalization of caveolin-1 with MMP-2 in ventricular myocytes [118] , suggesting that caveolin-1 has distinct roles in ventricles. Defining the signaling events regulated by caveolin-1 and caveolin-3 in cardiac myocytes and in different cardiac regions will be important future investigations. Of note, localization of components in caveolae in sinoatrial regions appears to be important for automaticity in the heart [119 ] .
Conclusion
Since the discovery of caveolae in the 1950s [120, 121] , scientists have been spelunkers in these 'caves' for more than 50 years in search of understanding their role in physiology and pathophysiology. Caveolae/rafts, lipid-rich platforms in a sea of fluidity, serve as nexuses for signal transduction in virtually all cells and tissues. Deletion of caveolin genes in knockout mice is not lethal, but absence of caveolins can alter numerous cellular processes [16] and reduce life span [94] ; recent data indicate that restoring endothelial-specific caveolin-1 expression in caveolin-1 knockout mice can rescue vascular, cardiac and pulmonary defects observed in such mice [122 ] . Caveolae house a large number of signaling molecules, probably too many in number and concentration to be explained by binding to the CSD. Are there subtypes of caveolae that have unique roles in compartmentation of signaling molecules? Do posttranslational modifications of caveolins (e.g. phosphorylation, nitrosylation, ubiquitination) regulate the binding of signaling partners to caveolins? Recent evidence suggests that caveolae may be conduits of signaling to nonplasma membrane regions. Understanding how caveolae link to sarcoplasmic reticulum, mitochondria, nuclei and other cellular compartments may reveal unexpected insights regarding the control of cellular function. The growing number of cellular and animal models of caveolin-associated diseases argues for the need to generate tissue and cell-specific [122 ,123] , as well as ageconditional, expression and knockdown of caveolins so as to achieve a more precise assessment of caveolins in pathophysiology. Thus, many unanswered issues remain with respect to rafts/caveolins, although their role in the regulation in cardiovascular cells seems unquestioned.
Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (p. 94). 
